More than 100 speakers and presenters are confirmed for ICPR 2022.
A majority and wide selection of presentations will be live-streamed.

Some ICPR 2022 Speakers

Kim Kuypers

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Paul Stamets

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Rick Doblin

Founder and Executive Director of MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Leonie Schneider

Co-Founder of PsyPAN and facilitator on the ACER Integration programme, United Kingdom

Amanda Feilding

Founder and Executive Director of the Beckley Foundation, United Kingdom

Bernardo Kastrup

Executive Director of Essentia Foundation / Author, Philosopher, Computer Scientist, the Netherlands

Tehseen Noorani

Senior Lecturer in Clinical & Community Psychology and Anthropology at the University of East London, United Kingdom

David Nutt

Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Erika Dyck

Professor and Canada Research Chair in the History of Health & Social Justice at the University of Saskatchewan

David Nichols

Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Roland Griffiths

Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University, United States

Winston De La Haye

Consultant General & Addiction Psychiatrist, University Hospital of the West Indies, Jamaica

Katrin Preller

Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, Switzerland

Friederike Holze

Postdoctoral researcher at University Hospital Basel, Switzerland

Gitte Moos Knudsen

Professor at Rigshospitalet and University of Copenhagen, Denmark

Janis Phelps

Director of the CIIS: California Institute of Integral Studies, United States

Mendel Kaelen

Founder and CEO at Wavepaths, United Kingdom

Monnica Williams

Research Chair for Mental Health Disparities, University of Ottawa. Principal Investigator for a multi-site study on MDMA-assisted psychotherapy for PTSD, Canada

Matthias Liechti

Professor for clinical pharmacology and internal medicine at the University Hospital Basel, Switzerland

Bill Richards

Psychologist at Johns Hopkins Center for Psychedelic & Consciousness Research and Director of Therapy at Sunstone Therapies, United States
The Pioneering and Leading Psychedelic Research Conference in Europe

Why Attend ICPR 2022?

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. The OPEN Foundation has been organising 5 large and international conferences since 2010.

About ICPR 2022

Who attends ICPR?

ICPR is a scientific conference for academics, researchers, clinicians, therapists, healthcare providers, policymakers, entrepreneurs, and members of the public.

Why attend ICPR?

ICPR features world’s leading experts in psychedelic research and therapies from across many fields, including psychiatry, neuroscience, psychology, and anthropology.

What's unique at ICPR?

ICPR is a podium for a wide variety of ideas, disciplines, perspectives, localities, individuals, and communities involved in advancing psychedelic research and therapies.

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.
The most recent ICPR 2022 updates

ICPR News

Goodbye ICPR 2022. Hello… ICPR 2024!

From touching talks to insightful perspectives, and profound new ways of thinking about reality to practical tips about doing therapy or research: ICPR 2022 has been an inspiring, thought-provoking, educational, and uplifting experience. Thanks to you all so much from the bottom of our hearts, whether you were a visitor, volunteer, speaker, presenter, digital visitor, or fan from afar: you made this conference what it was.

Read More

ICPR 2022 PREVIEW: SATURDAY

Wow, we’re already on the final day of ICPR 2022! We’ll hear from Roland Griffiths (virtually), trial participants, Rick Doblin, Gitte Moos Knudsen, Bernardo Kastrup and others on topics such as MDMA-assisted psychotherapy, indigenous medicine, business, microdosing, and critical perspectives on the quality of psychedelic research. 

Read More

ICPR 2022 PREVIEW: FRIDAY

On day two of ICPR 2022, we’ll get the chance to hear from Bill Richards, David Nutt and Amanda Fielding and others on everything from palliative care and Deleuzian theory to cognition and perception, therapeutic models and cultural competency in psychedelic care.

Read More

ICPR 2022 PREVIEW: THURSDAY

After many months of planning, ICPR 2022 is finally here! In this post, we’d like to look ahead to the first day of ICPR: Thursday. Here are some highlights, to help you with your planning for the three days of psychedelic science.

Read More

Sustainability & Reciprocity

We are extremely happy to be able to socialise with all of you soon at ICPR 2022. Yet we are fully aware of multiple ongoing crises right now. Out of care and concern for our living environment and other species, we decided to reduce ICPR’s ecological footprint per person compared to earlier conferences.

Read More

Some practical tips about flying into the Netherlands

As you start to plan your trip, we wanted to fill you in on a few important things to know about luggage and travel, as there have been plenty of crisis plaguing the world recently and the Netherlands is no exception.

Read More
Testimonials from Speakers & Attendees

Why People Love Attending ICPR

Get Your ICPR 2022
Livestream Ticket Now

Want The Latest Updates?

Subscribe below to ICPR Newsletter and get all the latest updates, including discount tickets!

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy & terms.